Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box-Behnken design and <i>in vivo</i> evaluation.

Shukr, Marwa H; Ismail, Soha; El-Hossary, Ghada G; El-Shazly, Amany H

Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box-Behnken design and in vivo evaluation.

Shukr, Marwa H; Ismail, Soha; El-Hossary, Ghada G; El-Shazly, Amany H.

Afiliação

Shukr MH; Department of Pharmaceutics, Egyptian Drug Authority Formerly Known As National Organization for Drug Control and Research (NODCAR), Giza, Egypt.
Ismail S; Department of Pharmaceutics, Egyptian Drug Authority Formerly Known As National Organization for Drug Control and Research (NODCAR), Giza, Egypt.
El-Hossary GG; Department of Pharmacology, Research Institute of Ophthalmology, Giza, Egypt.
El-Shazly AH; Department of Pharmacology, Research Institute of Ophthalmology, Giza, Egypt.

J Liposome Res ; 32(4): 354-364, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35037560

Assuntos

Portadores de Fármacos; Glaucoma; Humanos; Sistemas de Liberação de Medicamentos; Travoprost; Lipossomos; Tamanho da Partícula; Géis; Glaucoma/tratamento farmacológico

Palavras-chave

Travoprost; edge activator; spanlastic nano-vesicles; ocular insert

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Glaucoma Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google